Gastric Cancer

, Volume 20, Issue 6, pp 960–969 | Cite as

Expression and function of Uc.160+, a transcribed ultraconserved region, in gastric cancer

  • Ririno Honma
  • Keisuke Goto
  • Naoya Sakamoto
  • Yohei Sekino
  • Kazuhiro Sentani
  • Naohide Oue
  • Wataru Yasui
Original Article



Transcribed ultraconserved regions (T-UCRs) are a novel class of noncoding RNAs that are highly conserved among the orthologous regions in most vertebrates. It has been reported that T-UCRs have distinct signatures in human cancers. We previously discovered the downregulation of T-UCR expression in gastric cancer (GC), indicating that T-UCRs could play an important role in GC biology. Uc.160+, a T-UCR reported to be downregulated in human cancer, has not been examined in GC.


We analyzed the expression pattern of Uc.160+ in nonneoplastic and tumor tissues of the stomach by using uantitative reverse transcription polymerase chain reaction (qRT-PCR) and in situ hybridization (ISH), specifically focusing on the mechanism of transcriptional regulation and target genes that are regulated by T-UCRs. We also attempted to determine the effect of Uc.160+ expression on biological features of GC cell lines by Western blotting.


On the basis of the qRT-PCR and ISH results, Uc.160+ expression in adenoma and GC tissues was clearly downregulated compared with that in nonneoplastic mucosa tissues of the stomach. Cancer-specific DNA methylation in the promoter region of Uc.160 was observed by bisulfite genomic DNA sequencing analysis. The effect of DNA methylation on Uc.160+ expression was further confirmed by reporter gene assay. We also revealed that Uc.160+ inhibited the phosphorylation of Akt by regulating phosphatase and tensin homolog (PTEN) expression.


These results indicate that Uc.160+ could possibly have a tumor suppressive role in GC.


Gastric cancer Noncoding RNA Transcribed ultraconserved region DNA methylation 



We thank Shinichi Norimura for excellent technical assistance. We thank the Analysis Center of Life Science, Hiroshima University, for the use of its facilities. This work was supported by Grants-in-Aid for Scientific Research (JP15H04713, JP16K08691) and Grants-in-Aid for Challenging Exploratory Research (26670175, JP16K15247) from the Japan Society for the Promotion of Science.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Human rights statement and informed consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for their being included in the study.

Supplementary material

10120_2017_714_MOESM1_ESM.tif (562 kb)
Fig. S1 Functional analysis using Uc.160+-silenced cancer cells. a Uc.160+ expression in normal colon and colon cancer cells. b Uc.160+ expression in DLD-1 cells transfected with negative control or two different small interfering RNAs. c The growth-promotive effect of Uc.160+ knockout in DLD-1 cells. The results are expressed as the mean ± standard deviation of triplicate measurements (TIFF 562 kb).
10120_2017_714_MOESM2_ESM.xlsx (40 kb)
Table S1 A 260/A 280 ratios (XLSX 40 kb).


  1. 1.
    Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.CrossRefPubMedGoogle Scholar
  2. 2.
    Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, et al. Ultraconserved elements in the human genome. Science. 2004;304:1321–5.CrossRefPubMedGoogle Scholar
  3. 3.
    Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007;12:215–29.CrossRefPubMedGoogle Scholar
  4. 4.
    Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, et al. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene. 2010;29:6390–401.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell. 2004;5:121–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichinose M, et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer. 2009;124:2367–74.CrossRefPubMedGoogle Scholar
  7. 7.
    Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010;70:1430–40.CrossRefPubMedGoogle Scholar
  8. 8.
    Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 2011;71:7187–97.CrossRefPubMedGoogle Scholar
  9. 9.
    Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 1999;59:5438–42.PubMedGoogle Scholar
  10. 10.
    Zouridis H, Deng N, Ivanova T, Zhu Y, Wong B, Huang D, et al. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med. 2012;4:156ra40.CrossRefGoogle Scholar
  11. 11.
    Goto K, Ishikawa S, Honma R, Tanimoto K, Sakamoto N, Sentani K, et al. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation. Oncogene. 2016;27:3598–606.CrossRefGoogle Scholar
  12. 12.
    Hamai Y, Oue N, Mitani Y, Nakayama H, Ito R, Matsusaki K, et al. DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma. Cancer Sci. 2003;94:692–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, et al. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci. 2003;94:901–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Matsumura S, Oue N, Mitani Y, Kitadai Y, Yasui W. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer. Int J Cancer. 2007;120:1689–95.CrossRefPubMedGoogle Scholar
  15. 15.
    Naito Y, Oue N, Hinoi T, Sakamoto N, Sentani K, Ohdan H, et al. Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer. PLoS ONE. 2012;7:e47545.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Sakamoto N, Oue N, Sentani K, Anami K, Uraoka N, Naito Y, et al. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer. Cancer Sci. 2012;103:1744–50.CrossRefPubMedGoogle Scholar
  17. 17.
    Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Zarni Oo H, et al. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. Cancer Sci. 2014;105:236–43.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Oo HZ, Sentani K, Sakamoto N, Anami K, Naito Y, Uraoka N, et al. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer. Oncol Rep. 2014;32:403–10.CrossRefPubMedGoogle Scholar
  19. 19.
    Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, et al. Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer. Differentiation. 2001;68:13–21.CrossRefPubMedGoogle Scholar
  20. 20.
    Yasui W, Ayhan A, Kitadai Y, Nishimura K, Yokozaki H, Ito H, et al. Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer. 1993;53:36–41.CrossRefPubMedGoogle Scholar
  21. 21.
    Oue N, Naito Y, Hayashi T, Takigahira M, Kawano-Nagatsuma A, Sentani K, et al. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-alpha secretion in gastric cancer. Oncogene. 2014;33:3918–26.CrossRefPubMedGoogle Scholar
  22. 22.
    Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66.CrossRefPubMedGoogle Scholar
  23. 23.
    Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.CrossRefPubMedGoogle Scholar
  24. 24.
    Nobrega MA, Ovcharenko I, Afzal V, Rubin EM. Scanning human gene deserts for long-range enhancers. Science. 2003;302:413.CrossRefPubMedGoogle Scholar
  25. 25.
    Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M, et al. In vivo enhancer analysis of human conserved non-coding sequences. Nature. 2006;444:499–502.CrossRefPubMedGoogle Scholar
  26. 26.
    Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest. 2003;83:519–26.CrossRefPubMedGoogle Scholar
  27. 27.
    Lu XX, Yu JL, Ying LS, Han J, Wang S, Yu QM, et al. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer. 2012;118:5507–17.CrossRefPubMedGoogle Scholar
  28. 28.
    Neves Filho EH, Alves MK, Lima VP, Rabenhorst SH. MTHFR C677T polymorphism and differential methylation status in gastric cancer: an association with Helicobacter pylori infection. Virchows Arch. 2010;457:627–33.CrossRefPubMedGoogle Scholar
  29. 29.
    Peterson AJ, Menheniott TR, O’Connor L, Walduck AK, Fox JG, Kawakami K, et al. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans. Gastroenterology. 2010;139:2005–17.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Ferrasi AC. Helicobacter pyloriand EBV in gastric carcinomas: methylation status and microsatellite instability. World J Gastroenterol. 2010;16:312.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Liu Z, Xu X, Chen L, Li W, Sun Y, Zeng J, et al. Helicobacter pylori CagA inhibits the expression of Runx3 via Src/MEK/ERK and p38 MAPK pathways in gastric epithelial cell. J Cell Biochem. 2012;113:1080–6.CrossRefPubMedGoogle Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2017

Authors and Affiliations

  • Ririno Honma
    • 1
  • Keisuke Goto
    • 2
  • Naoya Sakamoto
    • 1
  • Yohei Sekino
    • 1
  • Kazuhiro Sentani
    • 1
  • Naohide Oue
    • 1
  • Wataru Yasui
    • 1
  1. 1.Department of Molecular PathologyHiroshima University Institute of Biomedical and Health SciencesHiroshimaJapan
  2. 2.Cancer Biology ProgramUniversity of Hawaii Cancer CenterHonoluluUSA

Personalised recommendations